| Announce Date | 08/19/2025 |
| EPS Normalized Actual | $1.26 (Beat by $0.03) |
| EPS GAAP Actual | $1.26 (Beat by $0.03) |
| Revenue Actual | $8.578B |
| Revenue Surprise | Beat by $8578M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Apr 2030 | 7.65 | 11.86 | 7.51335 | 7.76904 | 5 |
| Apr 2030 | 7.6 | 11.93 | 7.49259 | 7.73134 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 0.81 | 0.81 | 8.578B | 7.73% | 8578M |
| FQ2 2025 (Apr 2025) | 0.82 | 0.82 | 8.927B | 3.79% | 8927M |
| FQ1 2025 (Jan 2025) | -1.8 | -1.8 | 8.292B | 2.45% | 8292M |
| FQ4 2024 (Oct 2024) | 0.99 | 0.99 | 8.403B | 4.99% | 8403M |
| FQ3 2024 (Jul 2024) | 0.81 | 0.81 | 7.915B | 2.69% | 7915M |
| FQ2 2024 (Apr 2024) | 0.49 | 0.49 | 8.589B | 0.52% | 8589M |
| FQ1 2024 (Jan 2024) | 0.99 | 0.99 | 8.089B | 4.48% | 8089M |
| FQ4 2023 (Oct 2023) | 0.68 | 0.68 | 7.984B | 5% | 7984M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Apr 2028) | 0 | -- | 0 | 0 | 21 |
| FQ1 2028 (Jan 2028) | 0 | -- | 0 | 0 | 20 |
| FQ4 2027 (Oct 2027) | 0 | -- | 0 | 0 | 16 |
| FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 13 |
| FQ2 2027 (Apr 2027) | 1.80719 | -- | 1.79903 | 1.81552 | 12 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Apr 2028) | 10.29B | -- | 10.26B | 10.33B | 12 |
| FQ1 2028 (Jan 2028) | 9.72B | -- | 9.68B | 9.78B | 23 |
| FQ4 2027 (Oct 2027) | 9.6B | -- | 9.57B | 9.64B | 19 |
| FQ3 2027 (Jul 2027) | 9.3B | -- | 9.27B | 9.33B | 13 |
| FQ2 2027 (Apr 2027) | 9.68B | -- | 9.65B | 9.72B | 17 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 0.81 | 0.81 | 100% | |
| FQ2 2025 (Apr 2025) | 0.82 | 0.82 | 100% | |
| FQ1 2025 (Jan 2025) | -1.8 | -1.8 | 100% | |
| FQ4 2024 (Oct 2024) | 0.99 | 0.99 | 100% | |
| FQ3 2024 (Jul 2024) | 0.81 | 0.81 | 100% | |
| FQ2 2024 (Apr 2024) | 0.49 | 0.49 | 100% | |
| FQ1 2024 (Jan 2024) | 0.99 | 0.99 | 100% | |
| FQ4 2023 (Oct 2023) | 0.68 | 0.68 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | $0B | $8.58B | $8578M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $8.93B | $8927M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $8.29B | $8292M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $8.4B | $8403M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $7.92B | $7915M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $8.59B | $8589M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $8.09B | $8089M | 100% |
| FQ4 2023 (Oct 2023) | $0B | $7.98B | $7984M | 100% |